Effectiveness of Large Language Model-Based Chatbot Among Female University Stdents in Improving HPV Vaccine Awareness, Intention and Vaccination Rates
A Study on the Effectiveness of Large Language Model-Based Chatbot Interventions Among Female University Stdents in Improving HPV Vaccine Awareness, Intention and Vaccination Rates
1 other identifier
interventional
18,000
0 countries
N/A
Brief Summary
This is an interventional study targeting female university students. The primary objective of the study is to evaluate the effectiveness of a vaccine chatbot in improving HPV vaccination rates. The secondary objectives are to evaluate the effectiveness in improving vaccine awareness and vaccination intention. All participants will be enrolled and randomly assigned to four groups: (1) vaccine chatbot plus scientific videos, (2) vaccine chatbot only, (3) scientific videos only, and (4) a control group (no intervention). The chatbot will provide immediate, validated answers to participants' HPV vaccine-related questions. The scientific videos will cover content related to HPV vaccine safety, efficacy, and other relevant information. The study will compare changes in HPV vaccine awareness, vaccination intention, and vaccination behavior between the intervention groups and the control group after the intervention to evaluate whether the three intervention strategies enhance HPV vaccine awareness, vaccination intention, and vaccination uptake.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Apr 2026
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 25, 2025
CompletedFirst Posted
Study publicly available on registry
January 20, 2026
CompletedStudy Start
First participant enrolled
April 1, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 31, 2027
March 31, 2026
March 1, 2026
1.8 years
December 25, 2025
March 25, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
HPV vaccination rates for female university students in all groups before and after the intervention
Whether female university students get vaccinated against HPV or have an appointment for vaccination, measured by self-report and validated by vaccination information system
Baseline and two months
Secondary Outcomes (2)
HPV vaccine awareness for eligible female university students in all groups before and after the intervention
Baseline and two weeks
HPV vaccination intention for eligible female university students in all groups before and after the intervention
Baseline and two weeks
Other Outcomes (3)
Vaccine chatbot acceptability and implementability
Two weeks
Factors influencing vaccination intention for eligible female university students
Two weeks and six months
HPV vaccination rates for female university students in all groups after the intervention
two weeks, one month and six months
Study Arms (4)
Vaccine chatbot + Watching scientific videos group
EXPERIMENTALThe chatbot will provide immediate, validated answers to participants' HPV vaccine-related questions. Scientific videos cover content related to HPV vaccine safety, efficacy, and other relevant information.
Watching scientific videos group
EXPERIMENTALScientific videos cover content related to HPV vaccine safety, efficacy, and other relevant information.
Vaccine chatbot group
EXPERIMENTALThe chatbot will provide immediate, validated answers to participants' HPV vaccine-related questions.
Control group
NO INTERVENTIONNo intervention
Interventions
Provide scientific videos related to HPV vaccine
Provide vaccine chatbot to answer HPV vaccine questions
Eligibility Criteria
You may qualify if:
- Female university students.
- Possess an electronic device with QR code scanning capability.
- Female university students have no contraindications to HPV vaccination.
- No mental disorders or visual/reading impairments; able to cooperate with and implement the corresponding intervention activities.
- Have provided informed consent and are willing to participate in the study.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
December 25, 2025
First Posted
January 20, 2026
Study Start
April 1, 2026
Primary Completion (Estimated)
December 31, 2027
Study Completion (Estimated)
December 31, 2027
Last Updated
March 31, 2026
Record last verified: 2026-03